1. Volume 145, Issue 2, Pages 357-365.e2 (August 2013)
Young Women With Polycystic Liver Disease Respond Best to Somatostatin Analogues: A Pooled Analysis of Individual Patient Data 
Tom J.G. Gevers, Joanna Inthout, Anna Caroli, Piero Ruggenenti, Marie C. Hogan, Vicente E. Torres, Frederik Nevens, Joost P.H. Drenth 
Gastroenterology 
Volume 145, Issue 2, Pages e2 (August 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Risk of bias summary: review of authors' judgments about each risk of bias item for each included study. −, low risk of bias; ?, unclear risk of bias; +, high risk of bias.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Estimated percent changes (mean ± 95% CI) in liver volumes in ADPKD and PCLD patients treated with somatostatin analogues or placebo for 6−12 months, calculated by multiple linear regression analysis.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Figure 3
Estimated percent changes (mean ± 95% CI) in liver volumes in age−sex groups treated with somatostatin analogues or placebo for 6−12 months, calculated by multiple linear regression analysis.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

5. Supplementary Figure 1 Flow diagram of selection articles.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

6. Supplementary Figure 2
Percent changes in liver volume for all treatment periods. Each bar represents 1 treatment period (n = 119).
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

7. Supplementary Figure 3
Estimated percent changes (mean ± 95% CI) in liver volume in all patients treated with somatostatin analogues or placebo for 6−12 months, calculated by linear multiple linear regression analysis.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

8. Supplementary Figure 4
Estimated percent changes (mean ± 95% CI) in liver volumes in men and women treated with somatostatin analogues or placebo for 6−12 months, calculated by multiple linear regression analysis.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

9. Supplementary Figure 5
Estimated percent changes (mean ± 95% CI) in liver volumes in age subgroups (median of 48 years as a cut-off value) treated with somatostatin analogues or placebo for 6−12 months, calculated by multiple linear regression analysis.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions